Medical Marijuana, Inc. (MJNA)

MJNA-LOGOMedical Marijuana, Inc. is comprised of a diversified portfolio of products, technology, businesses, and services exclusively focused on the production of high concentrate hemp oil products that are rich in cannabinoid (CBD). The company’s products range from proprietary and patented cannabinoid-based products to seed and stalk, or isolated high-value extracts formulated and manufactured for the nutraceutical, pharmaceutical, cosmeceutical, and food industries.

The services offered by Medical Marijuana, Inc. are extensive and varied. Such services range from medical clinic management to the capitalization of existing businesses and product leaders in the industry. The company also provides development of CBD-based health and wellness products and of medical-grade compounds.

Medical Marijuana, Inc. provides more than 85 proprietary and patent-pending delivery methods of cannabinoid that are more acceptable both medically and socially than the typical delivery methods in the industry. The company’s services also include licensing of its proprietary testing, packaging, genetics, labeling, production, tracking, and standardization methods for the medicinal herb industry.

The California-based Medical Marijuana, Inc. has an impressive portfolio of businesses that includes HempMeds PX, CanChew Gum, Canipa Holdings, Phytosphere, KannaLife Sciences, Red Dice Holdings, and Wellness Managed Services. These businesses, whether wholly or partially owned by Medical Marijuana, Inc., are integral pieces of the company’s business. The company’s featured products include Real Scientific Hemp Oil, Cibdex, Cibaderm, and Dixie Botanicals.

Founded in 2003, Medical Marijuana, Inc. is a publicly traded holding company that trades in the OTC market under the stock symbol MJNA. The company’s mission is to become the premier innovators in the hemp and cannabis industry, leveraging their team of professionals into sourcing, evaluating, and purchasing value-added products and companies while allowing them to retain their entrepreneurial spirit and integrity. Medical Marijuana, Inc. strives to create awareness within the industry, develop economically-stable and environmentally-friendly businesses while increasing shareholder value.


Yahoo! Finance: MJNA News

Latest Financial News for MJNA

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil

Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that subsidiary HempMeds® Brasil applauds ANVISA (the National Agency for Health Supervision) for unanimously approving the regulation of medical marijuana to be sold at pharmacies and drugstores nationwide. Brazil's new regulations will be published soon on the Federal Official Gazette and entered into law 90 days after that.

Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 Best in Biz Awards

Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® received a Bronze Best in Biz Award for Most Innovative Product of the Year – Consumer for its high-quality hemp-derived cannabidiol (CBD) products. Also, Kannaway® CEO Blake Schroeder received a Bronze Award for Executive of the Year – Small Companies.

The US Cities Most Interested In Cannabis

While cannabis has gone from a criminalized drug to a multibillion-dollar boom in recent years, very little data exists on how interest and consumer demand differ around the country, according to Michael Coleman, the vice president of sales and marketing at Medical Marijuana Inc (OTC: MJNA), told Benzinga. "We believe this study can be useful for cannabis executives and entrepreneurs who are looking to make strategic decisions about which markets to enter," he said of the company's most recent report on geographical interest on cannabis across the U.S. The following are highlights from Medical Marijuana Inc.'s report on interest in marijuana in cities nationwide.

Medical Marijuana, Inc. Reports $17.7 Million in Revenue in Q3 2019 Financial Results

SAN DIEGO , Nov. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Invited to Speak on Key Panel at 2019 Marijuana Business Conference

Caroline Heinz will speak on Dec. 12 at 2:00 p.m. on a panel entitled "Beyond Borders: Looking at Latin America as the New Frontier" discussing business opportunities allowed by regulations throughout Latin America, the current status of key revenue markets, challenges in each Latin American region and how they are being addressed, and Latin American cannabis investment opportunities. "Just like the U.S., Latin America is currently experiencing monumental shifts in acceptance and new legislation," Heinz said.